A topical treatment combining calcipotriol and 5-FU shows promise in reducing premalignant lesions and lowering skin cancer ...

Our dogs can offer us more than just companionship - they have an incredible ability to detect a range of illnesses in humans ...

The number of cancer cases is expected to cross the two million mark in 2024 -- the first time ever -- according American ...

A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic ...

Cemiplimab significantly reduced the risk of recurrence or death in patients with high-risk cutaneous squamous cell carcinoma ...

Rates of breast and thyroid cancer for women under 50 rose from 2002 to 2021, while men in the same age group had declining ...

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

Trial remains on track for completion and data readout in the second half of 2025COPENHAGEN, Denmark, January 15, 2025 - Evaxion Biotech A/S ...

He noted that the current management options leave patients ... with this innovative treatment. The urgency of developing effective therapies for skin cancer in transplant patients is underscored ...

Cancers of the eye are exceedingly rare, and only a rare handful of cancer clinics in the nation are equipped to deal with ...

Researchers at Newcastle University in the UK have developed a groundbreaking tool called “DeepMerkel,” powered by artificial ...